Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Rongcan Shikang Life Technology

Request full access

Committed to the development and industrialization of nucleic acid drugs

ChinaBiotech & Life Sciences

About Shanghai Rongcan Shikang Life Technology

RongCan Biotech is a pioneering company in the field of nucleic acid-based medicines, leveraging proprietary RNA and lipid nanoparticle (LNP) technologies to develop innovative treatments for various human diseases. The company operates in the biotechnology and pharmaceutical markets, focusing on the prevention and treatment of diseases by regulating target gene expression and protein function. RongCan Biotech serves a diverse range of clients, including hospitals, infectious disease prevention and control units, scientific research institutes, and contract research organizations (CROs). The business model is centered around the development and commercialization of its proprietary RNA-based Therapeutic Platform (RTP), which includes LNP-based mRNA and siRNA delivery systems. These systems are designed to offer optimal safety and efficacy profiles, making them highly attractive for clinical applications. RongCan Biotech generates revenue through strategic collaborations, product development partnerships, and clinical cooperation agreements. The company is led by a team of scientists and engineers with extensive expertise in mRNA and LNP technologies, many of whom have trained at prestigious institutions such as MIT and Harvard Medical School. The company is committed to achieving win-win situations through cooperation with various stakeholders in the healthcare and scientific communities.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
24.3/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2023 $14M $55M Beijing Huafang Investment · Yuexiu Industrial Fund · Shaanxi Investment Growth Fund · Zhangjiagang Jintai Jinhong Fund ↗
EARLY VC✓Equity / VC Nov 2022 $2.8M $11M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Rongcan Shikang Life Technology website traffic

Latest recorded traffic for Shanghai Rongcan Shikang Life Technology is 450 monthly website visits, down 23.7% over the last three months.

Latest monthly visits450 3-month web change-23.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Rongcan Shikang Life Technology in its local ecosystem

Live from Dealroom

The Shanghai Rongcan Shikang Life Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Beijing Huafang Investment
  • Yuexiu Industrial Fund
  • Shaanxi Investment Growth Fund
  • Zhangjiagang Jintai Jinhong Fund
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Rongcan Shikang Life Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Rongcan Shikang Life Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.